Cargando…

Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy

OBJECTIVE: To compare the efficacy and influencing factors of initial radioactive iodine (RAI) ablation therapy for postoperative N1 stage papillary thyroid micro-carcinoma (PTMC) and papillary thyroid non-micro carcinoma (PTC), and to explore the necessity of RAI for N1 stage PTMC. METHODS: A retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Canhua, Wu, Meiling, Xiao, Juan, Liu, Yong, Zhang, Wei, Cao, Jingjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887430/
https://www.ncbi.nlm.nih.gov/pubmed/33613032
http://dx.doi.org/10.2147/CMAR.S292395
_version_ 1783651981088260096
author Yun, Canhua
Wu, Meiling
Xiao, Juan
Liu, Yong
Zhang, Wei
Cao, Jingjia
author_facet Yun, Canhua
Wu, Meiling
Xiao, Juan
Liu, Yong
Zhang, Wei
Cao, Jingjia
author_sort Yun, Canhua
collection PubMed
description OBJECTIVE: To compare the efficacy and influencing factors of initial radioactive iodine (RAI) ablation therapy for postoperative N1 stage papillary thyroid micro-carcinoma (PTMC) and papillary thyroid non-micro carcinoma (PTC), and to explore the necessity of RAI for N1 stage PTMC. METHODS: A retrospective analysis of patients with N1 stage papillary thyroid cancer who underwent RAI in our department from January 2018 to June 2019. According to the tumor diameter, papillary thyroid carcinoma was divided into PTMC group (≤ 1.0cm) with 129 patients and PTC group (> 1.0 cm) with 214 patients. According to the 2015 ATA guidelines, the patient’s treatment response was evaluated 6–8 months after discharge from the hospital: excellent response (ER), indeterminate response (IDR), biochemical incomplete response (BIR), and structural incomplete response (SIR). IDR, BIR, and SIR were classified into NER group. Chi-squared test, independent sample t-test, Mann–Whitney U test, and binary logistic regression analysis were used to compare the differences between PTMC and PTC patients. RESULTS: The ps-Tg of the PTMC group was significantly lower than that of the PTC group (P = 0.001), and the ER ratio of the PTMC group was higher (χ(2) = 5.445, P < 0.05). The ER ratio of PTMC patients in the N1a group was significantly higher than that of PTC patients (80%, 66.7%, χ(2) = 4.076, P < 0.05), while the ER ratio of PTMC in the N1b group was not significantly different from that of PTC. Gender, N stage, and ps-Tg were found to be independent factors of RAI treatment response. CONCLUSION: The efficacy of the initial RAI of PTMC patients was significantly better than that of PTC patients. There was no significant difference in the efficacy of RAI between males with PTMC, N1b stage, ps-Tg ≥ 5.87ng/mL and PTC patients, which suggested that RAI is necessary for these patients.
format Online
Article
Text
id pubmed-7887430
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78874302021-02-18 Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy Yun, Canhua Wu, Meiling Xiao, Juan Liu, Yong Zhang, Wei Cao, Jingjia Cancer Manag Res Original Research OBJECTIVE: To compare the efficacy and influencing factors of initial radioactive iodine (RAI) ablation therapy for postoperative N1 stage papillary thyroid micro-carcinoma (PTMC) and papillary thyroid non-micro carcinoma (PTC), and to explore the necessity of RAI for N1 stage PTMC. METHODS: A retrospective analysis of patients with N1 stage papillary thyroid cancer who underwent RAI in our department from January 2018 to June 2019. According to the tumor diameter, papillary thyroid carcinoma was divided into PTMC group (≤ 1.0cm) with 129 patients and PTC group (> 1.0 cm) with 214 patients. According to the 2015 ATA guidelines, the patient’s treatment response was evaluated 6–8 months after discharge from the hospital: excellent response (ER), indeterminate response (IDR), biochemical incomplete response (BIR), and structural incomplete response (SIR). IDR, BIR, and SIR were classified into NER group. Chi-squared test, independent sample t-test, Mann–Whitney U test, and binary logistic regression analysis were used to compare the differences between PTMC and PTC patients. RESULTS: The ps-Tg of the PTMC group was significantly lower than that of the PTC group (P = 0.001), and the ER ratio of the PTMC group was higher (χ(2) = 5.445, P < 0.05). The ER ratio of PTMC patients in the N1a group was significantly higher than that of PTC patients (80%, 66.7%, χ(2) = 4.076, P < 0.05), while the ER ratio of PTMC in the N1b group was not significantly different from that of PTC. Gender, N stage, and ps-Tg were found to be independent factors of RAI treatment response. CONCLUSION: The efficacy of the initial RAI of PTMC patients was significantly better than that of PTC patients. There was no significant difference in the efficacy of RAI between males with PTMC, N1b stage, ps-Tg ≥ 5.87ng/mL and PTC patients, which suggested that RAI is necessary for these patients. Dove 2021-02-12 /pmc/articles/PMC7887430/ /pubmed/33613032 http://dx.doi.org/10.2147/CMAR.S292395 Text en © 2021 Yun et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yun, Canhua
Wu, Meiling
Xiao, Juan
Liu, Yong
Zhang, Wei
Cao, Jingjia
Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy
title Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy
title_full Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy
title_fullStr Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy
title_full_unstemmed Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy
title_short Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy
title_sort analysis of curative effect and influencing factors of n1 stage papillary thyroid micro-carcinoma and papillary thyroid non-micro carcinoma after initial radioactive iodine ablation therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887430/
https://www.ncbi.nlm.nih.gov/pubmed/33613032
http://dx.doi.org/10.2147/CMAR.S292395
work_keys_str_mv AT yuncanhua analysisofcurativeeffectandinfluencingfactorsofn1stagepapillarythyroidmicrocarcinomaandpapillarythyroidnonmicrocarcinomaafterinitialradioactiveiodineablationtherapy
AT wumeiling analysisofcurativeeffectandinfluencingfactorsofn1stagepapillarythyroidmicrocarcinomaandpapillarythyroidnonmicrocarcinomaafterinitialradioactiveiodineablationtherapy
AT xiaojuan analysisofcurativeeffectandinfluencingfactorsofn1stagepapillarythyroidmicrocarcinomaandpapillarythyroidnonmicrocarcinomaafterinitialradioactiveiodineablationtherapy
AT liuyong analysisofcurativeeffectandinfluencingfactorsofn1stagepapillarythyroidmicrocarcinomaandpapillarythyroidnonmicrocarcinomaafterinitialradioactiveiodineablationtherapy
AT zhangwei analysisofcurativeeffectandinfluencingfactorsofn1stagepapillarythyroidmicrocarcinomaandpapillarythyroidnonmicrocarcinomaafterinitialradioactiveiodineablationtherapy
AT caojingjia analysisofcurativeeffectandinfluencingfactorsofn1stagepapillarythyroidmicrocarcinomaandpapillarythyroidnonmicrocarcinomaafterinitialradioactiveiodineablationtherapy